Roger Li
@UrogerliMDUrologic oncologist @MoffittNews | Translational researcher | Views are my own
Similar User
@spsutkaMD
@pcvblack
@siadaneshmand
@SUO_YUO
@SurenaMatinMD
@SBoorjian
@Agarwal_CaB
@UroCancerMD
@WadeJSexton9
@sgilbert1973
@LoganZemp
@jimhumd
@SpiessPhilippe
@bbmdmsk
@urojdr
Excited to open the combination neoadjuvant trial combining IVe oncolytic virus #CG0070 and nivo in cis-ineligible patients with #MIBC @MoffittNews Looking forward to pursuing translational research looking for potential synergism in this combo moffitt.org/endeavor/archi…
@UrogerliMD calls it “a promising strategy with a favorable safety profile.” This innovative therapy could be a game-changer for those who need alternatives to traditional chemo. #MoffittAmbassador x.com/MoffittNews/st…
Join us in congratulating our President and CEO, @PatrickHwuMD, for being selected for the 2024 @FloridaTrend edition of the Florida 500! The special publication highlights the 500 most influential executives in different economic sectors throughout the state. We are so lucky to…
Comprehensive review of UTUC surgical management chemoprophaxis and surveillance by @BasileG_ @SpiessPhilippe @GTumors @BandiniMd @UrogerliMD journals.lww.com/co-urology/abs…
We would like to inform you that your post has been published on @Oncodaily Thank you for sharing! oncodaily.com/opinion/183394
The use of oncolytic virotherapy and nivolumab to treat muscle-invasive Bladder Cancer - @PatrickHwuMD @UrogerliMD @sitcancer oncodaily.com/url/183247 #SITC24 #BladderCancer #Cancer #ImmuneOnc #IO #ImmunoOncology #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
Cretostimogene grenadenorepvec plus nivolumab shows promise in cisplatin-ineligible MIBC urologytimes.com/view/cretostim… via @@urologytimes
Presented at #SITC2024: In a phase 1b trial, treatment of patients with muscle-invasive #BladderCancer with intravesical #OncolyticVirus cretostimogene grenadenorepvec in combination with #Nivolumab was safe and led to encouraging preliminary clinical response rates, by…
While at #SITC24, Roger Li, MD (@UrogerliMD) joined me to discuss his study evaluating the use of combination oncolytic virotherapy and immune checkpoint inhibitor nivolumab to treat muscle-invasive #BladderCancer. Check out our video below 👇 and read more about his work here-…
United States Trends
- 1. #PaulTyson 97,3 B posts
- 2. #SmackDown 18,5 B posts
- 3. Goyat 9.666 posts
- 4. Rosie Perez 1.275 posts
- 5. Cedric 5.439 posts
- 6. Bayley 4.790 posts
- 7. B-Fab 3.423 posts
- 8. Cam Thomas 1.995 posts
- 9. #NetflixBoxing N/A
- 10. CJ Cox N/A
- 11. Max Christie 1.064 posts
- 12. Purdue 4.716 posts
- 13. #FightNight 3.622 posts
- 14. Hukporti N/A
- 15. Karoline 36,8 B posts
- 16. Kevin Love 1.865 posts
- 17. Michin 3.167 posts
- 18. End 1Q N/A
- 19. Philon N/A
- 20. Paige 10,3 B posts
Who to follow
-
Sarah P. Psutka MD MS
@spsutkaMD -
Peter Black
@pcvblack -
Sia Daneshmand, M.D.
@siadaneshmand -
YUO
@SUO_YUO -
Surena F Matin MD
@SurenaMatinMD -
Stephen Boorjian, MD
@SBoorjian -
Piyush Kumar Agarwal
@Agarwal_CaB -
Sam S. Chang MD, MBA
@UroCancerMD -
Wade J Sexton
@WadeJSexton9 -
Scott Gilbert
@sgilbert1973 -
Logan Zemp
@LoganZemp -
Jim Hu
@jimhumd -
Philippe spiess
@SpiessPhilippe -
Bernie Bochner, MD
@bbmdmsk -
Jay Raman
@urojdr
Something went wrong.
Something went wrong.